drugset / Trial / NCT00239421
A Six-week Study Comparing the Efficacy and Safety of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in Chronic Obstructive Pulmonary Disease (COPD)
RandomizedParallel-groupDouble-blindTreatment
Summary
To compare the efficacy and safety of tiotropium plus formoterol in comparison to salmeterol plus fluticasone in COPD patients.
Timeline
- Start
- 2003-11
- Primary completion
- 2004-09
- Completion
- 2004-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluticasone propionate | Other / unclassified | 500 ug | Inhaled |
| Subject | Formoterol | Other / unclassified | 12 ug | Inhaled |
| Subject | Salmeterol | Other / unclassified | 50 ug | Inhaled |
| Subject | Tiotropium | Other / unclassified | 18 ug | Inhaled |